IIM
ESPR icon

INTECH Investment Management’s Esperion Therapeutics ESPR Stock Holding History

INTECH Investment Management’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$172K Sell
62,620
-42,318
-40% -$134K ﹤0.01% 1793
2025
Q4 		$388K Buy
104,938
+5,447
+5% +$17.6K ﹤0.01% 1628
2025
Q3 		$264K Sell
99,491
-23,549
-19% -$45.5K ﹤0.01% 1906
2025
Q2 		$121K Buy
123,040
+28,695
+30% +$28.7K ﹤0.01% 2244
2025
Q1 		$136K Buy
94,345
+12,960
+16% +$23.9K ﹤0.01% 2224
2024
Q4 		$179K Buy
81,385
+24,481
+43% +$57.1K ﹤0.01% 2068
2024
Q3 		$93.9K Buy
+56,904
New +$115K ﹤0.01% 1894

Other funds holding ESPR

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $2.17B AUM 169.27% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return